Cargando…
The CagRS Two-Component System Regulates Clavulanic Acid Metabolism via Multiple Pathways in Streptomyces clavuligerus F613-1
Streptomyces clavuligerus F613-1 produces a clinically important β-lactamase inhibitor, clavulanic acid (CA). Although the biosynthesis pathway of CA has essentially been elucidated, the global regulatory mechanisms of CA biosynthesis remain unclear. The paired genes cagS and cagR, which are annotat...
Autores principales: | Fu, Jiafang, Qin, Ronghuo, Zong, Gongli, Liu, Cheng, Kang, Ni, Zhong, Chuanqing, Cao, Guangxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382702/ https://www.ncbi.nlm.nih.gov/pubmed/30837970 http://dx.doi.org/10.3389/fmicb.2019.00244 |
Ejemplares similares
-
Complete Genome Sequence of Streptomyces clavuligerus F613-1, an Industrial Producer of Clavulanic Acid
por: Cao, Guangxiang, et al.
Publicado: (2016) -
The two-component system CepRS regulates the cephamycin C biosynthesis in Streptomyces clavuligerus F613-1
por: Fu, Jiafang, et al.
Publicado: (2019) -
Rich Organic Nitrogen Impacts Clavulanic Acid Biosynthesis through the Arginine Metabolic Pathway in Streptomyces clavuligerus F613-1
por: Fu, Jiafang, et al.
Publicado: (2022) -
Draft Genome Sequence of the Tacrolimus-Producing Bacterium Streptomyces tsukubaensis F601
por: Zong, Gongli, et al.
Publicado: (2017) -
Complete Genome Sequence of the High-Natamycin-Producing Strain Streptomyces gilvosporeus F607
por: Zong, Gongli, et al.
Publicado: (2018)